Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic
Commercial Insight: Antihypertensives - Can Manufacturers Maintain Value?
Datamonitor, Oct 2004, Pages: 89
Description
Table of Contents
Enquire before Buying
Send to a Friend
CHAPTER 1 EXECUTIVE SUMMARY 3
Objective of the analysis 3
Our insight into the hypertension market 4
CHAPTER 2 CURRENT MARKET ASSESSMENTS 9
Strategic scoping and focus 9
Market definition for this report 10
Antihypertensive drug classes 11
Global overview 19
Global: current market assessment 20
National markets 26
Leading global brands 27
Market issues 28
US: current market assessment 41
Overview 41
Market issues in the US 42
Japan: current market assessment 45
Overview 45
Market issues in Japan 46
European Union: current market assessment 48
Overview 48
Market issues in the EU5 49
Summary of environmental issues affecting antihypertensive market size 55
CHAPTER 3 FORECAST ANALYSIS 56
Assumptions and events 56
Ongoing trends 56
Trial results 56
New product launches 59
Patent expiries 60
ARB patent expiries 61
CCB patent expiries 63
Beta-blocker patent expiries 63
ACE inhibitor patent expiries 64
Other patent expiries 65
Additional indications 65
Methodology 67
Forecasts 67
CHAPTER 4 COMMERCIAL IMPACT AND LIFECYCLE MANAGEMENT: CASE STUDIES 68
Introduction 68
Clinical trials 69
Gaining novel additional indications 73
Entry strategy 76
APPENDIX A – MARKET DATA AND MAJOR BRAND KEY FACTS 80
Global hypertension market data 80
Therapeutic classification 80
APPENDIX B 83
Bibliography 83
Report methodology 85
General 85
Japan sales data 85
ATC codes 85
Key opinion leaders 85
Customers who bought this item also bought
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries
Forecast Insight: Antihypertensives - Key Patent Expiries Prevent Market Growth
Forecast Insight: Antihypertensives New fixed dose combinations unable to stem the tide of patent expiries
Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming Patent Expiries Limit Market Growth
Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products
Generic Cancer Market - New Legislation and a Wave of Patent Expiries to Transform the Market
Report on Antihypertensive Drug Market
Antihypertensives - Two Years to Shape the Market?
Commercial Insight: Antihypertensives - New Challenges for a Maturing Market
Stakeholder Opinions: Bone Metastases - Impending Patent Expiries May Help Make or Break Newer Agents
Market Dynamics 2000: Allergic Rhinitis: Effects of Major Patent Expiries On An Expanding Market
Commercial Insight: Cardiovascular Market Overview - Raft of Patent Expires Threaten Blockbusters
Top of page
All rights reserved. © Copyright 2009 Research and Markets
0
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster
